Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2018 1
2019 3
2020 2
2021 2
2022 2
2023 4
2024 1
2025 8
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Cannabis for Gastroparesis: Hype or Hope?
McCallum RW, Bashashati M. McCallum RW, et al. Am J Gastroenterol. 2019 Jun;114(6):865-866. doi: 10.14309/ajg.0000000000000277. Am J Gastroenterol. 2019. PMID: 31135448 No abstract available.
Cannabis Use in Patients with Gastroparesis.
Saleem S, Tarar ZI, Aziz M, Alsamman MA, Tansel A, Abell TL. Saleem S, et al. Cannabis Cannabinoid Res. 2023 Dec;8(6):1100-1105. doi: 10.1089/can.2022.0189. Epub 2022 Sep 6. Cannabis Cannabinoid Res. 2023. PMID: 36067326
Aim: The primary aim was to determine the prevalence of cannabis use among patients hospitalized for gastroparesis. The secondary aim was to identify independent variables associated with cannabis use compared with noncannabis-related gastroparesis hos …
Aim: The primary aim was to determine the prevalence of cannabis use among patients hospitalized for gastroparesis. The second …
Gastroparesis with Cannabis Use: A Retrospective Study from the Nationwide Inpatient Sample.
Dahiya DS, Kichloo A, Shaka H, Singh J, Edigin E, Solanki D, Eseaton PO, Wani F. Dahiya DS, et al. Postgrad Med. 2021 Sep;133(7):791-797. doi: 10.1080/00325481.2021.1940219. Epub 2021 Jun 15. Postgrad Med. 2021. PMID: 34096455
Background: With increasing utilization of cannabis in the United States (US), clinicians may encounter more cases of Gastroparesis (GP) in coming years.Objective: The primary outcome was inpatient mortality for GP with cannabis use. ...Of these hospitalizati …
Background: With increasing utilization of cannabis in the United States (US), clinicians may encounter more cases of Gastroparesi …
The Impact of Cannabis Use in Gastroparesis: A Propensity-Matched Analysis of 41,374 Gastroparesis Patients.
Kilani Y, Gonzalez Mosquera DA, Puelo PC, Aldiabat M, Ruffle JK, Madi MY, Farmer AD. Kilani Y, et al. Am J Gastroenterol. 2026 Jan 1;121(1):248-257. doi: 10.14309/ajg.0000000000003479. Epub 2025 Apr 8. Am J Gastroenterol. 2026. PMID: 40197432
RESULTS: Among 41,374 patients with gastroparesis, cannabis users (n = 20,687) and non-users (n = 20,687) were propensity-matched. ...DISCUSSION: Cannabis use in patients with gastroparesis seems to increase healthcare utilization. These findings under …
RESULTS: Among 41,374 patients with gastroparesis, cannabis users (n = 20,687) and non-users (n = 20,687) were propensity-matc …
Trends and Socioeconomic Health Outcomes of Cannabis Use Among Patients With Gastroparesis: A United States Nationwide Inpatient Sample Analysis.
McCarty TR, Chouairi F, Hathorn KE, Chan WW, Thompson CC. McCarty TR, et al. J Clin Gastroenterol. 2022 Apr 1;56(4):324-330. doi: 10.1097/MCG.0000000000001526. J Clin Gastroenterol. 2022. PMID: 33780213 Free PMC article.
BACKGROUND: Although cannabis may worsen nausea and vomiting for patients with gastroparesis, it may also be an effective treatment for gastroparesis-related abdominal pain. ...RESULTS: A total of 1,473,363 patients with gastroparesis were analyzed [n= …
BACKGROUND: Although cannabis may worsen nausea and vomiting for patients with gastroparesis, it may also be an effective trea …
Cannabinoids and the Gastrointestinal Tract.
Camilleri M, Zheng T. Camilleri M, et al. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3217-3229. doi: 10.1016/j.cgh.2023.07.031. Epub 2023 Sep 9. Clin Gastroenterol Hepatol. 2023. PMID: 37678488 Free PMC article. Review.
The CB(2)-receptor agonist, cannabidiol, reduced the total Gastroparesis Cardinal Symptom Index and increases the ability to tolerate a meal in patients with gastroparesis appraised over 4 weeks of treatment. ...In conclusion, cannabinoids, particularly agents affec …
The CB(2)-receptor agonist, cannabidiol, reduced the total Gastroparesis Cardinal Symptom Index and increases the ability to tolerate …
Differentiating Diabetic Gastroparesis and Cannabis Hyperemesis Syndrome in People With Type 1 Diabetes.
Akturk HK, Mason E, Snell-Bergeon J, Shah VN, Karakus KE. Akturk HK, et al. Clin Diabetes. 2025 Mar 7;43(3):416-419. doi: 10.2337/cd24-0096. eCollection 2025 Summer. Clin Diabetes. 2025. PMID: 40741458 Free PMC article.
Cannabinoid hyperemesis syndrome (CHS) is recurrent nausea, vomiting, and abdominal pain due to prolonged cannabis use. This study aimed to differentiate the significant overlap in presentations of diabetic gastroparesis (DG) and CHS in people with type 1 diabetes. …
Cannabinoid hyperemesis syndrome (CHS) is recurrent nausea, vomiting, and abdominal pain due to prolonged cannabis use. This study ai …
A Randomized, Controlled Trial of Efficacy and Safety of Cannabidiol in Idiopathic and Diabetic Gastroparesis.
Zheng T, BouSaba J, Taylor A, Dilmaghani S, Busciglio I, Carlson P, Torres M, Ryks M, Burton D, Harmsen WS, Camilleri M. Zheng T, et al. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3405-3414.e4. doi: 10.1016/j.cgh.2023.07.008. Epub 2023 Jul 22. Clin Gastroenterol Hepatol. 2023. PMID: 37482172 Free PMC article. Clinical Trial.
BACKGROUND & AIMS: Cannabis (delta-9-tetrahydrocannabinol), a nonselective cannabinoid-receptor agonist, relieves nausea and pain. ...CONCLUSIONS: CBD provides symptom relief in patients with gastroparesis and improves the tolerance of liquid nutrient intake, de …
BACKGROUND & AIMS: Cannabis (delta-9-tetrahydrocannabinol), a nonselective cannabinoid-receptor agonist, relieves nausea and pain …
23 results